Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.06.2023 | Case report

Antineoplastics

Diabetes mellitus, adrenal insufficiency and lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Nakamura T, et al. End-of-life impact of concurrent diabetes mellitus and adrenal insufficiency as immune-related adverse events in an advanced non-small cell lung cancer patient. Thoracic Cancer 13: 3073-3075, No. 21, Nov 2022. Available from: URL: http://doi.org/10.1111/1759-7714.14660 Nakamura T, et al. End-of-life impact of concurrent diabetes mellitus and adrenal insufficiency as immune-related adverse events in an advanced non-small cell lung cancer patient. Thoracic Cancer 13: 3073-3075, No. 21, Nov 2022. Available from: URL: http://​doi.​org/​10.​1111/​1759-7714.​14660
Metadaten
Titel
Antineoplastics
Diabetes mellitus, adrenal insufficiency and lack of efficacy: case report
Publikationsdatum
01.06.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-41303-0

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Heparin

Case report

Azd-1222